━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
TECHNOLOGY TRANSFER PACKAGE
P-13
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

**TECHNICAL READINESS**: T1
**TRANSFER POSTURE**: DECISIVE_EXPERIMENT_REQUIRED
**COMMERCIAL STATE**: UNCONTACTED
**VALIDATION**: VALID

**ONE-LINE BUYER TRUTH**
A computationally specified P-13 concept plus a preregistered decisive experiment — not a validated technology.

**EXECUTIVE PROPOSITION**
Technology: ML-based predictor using ICP + flow trends to forecast failure 24h before symptoms. Problem: Shunt failure prediction is reactive (symptoms then surgery). No predictive tool exists..

**BUYER PROBLEM**
Who: Hospital system / shunt OEM with clinical data access
Problem: Shunt failure prediction is reactive (symptoms then surgery). No predictive tool exists.
Current solution: Clinical monitoring (intermittent, reactive)

**TECHNOLOGY**
ML-based predictor using ICP + flow trends to forecast failure 24h before symptoms

**EVIDENCE LEDGER** (structured atoms — no blending)
  MODELLED:
    - claim: AUC >= 0.80 (not measured)
      scope: internal computational model
      limitation: model prediction — not experimentally verified
    - claim: Lead time >= 12h (not measured)
      scope: internal computational model
      limitation: model prediction — not experimentally verified
  ASSUMED:
    - claim: FAILED ASSUMPTION: Conditional on P-15/P-16 energy (if those fail, P-13 has no power source)
      scope: hostile attack or model test
      limitation: this assumption broke — buyer must not rely on it

**STRONGEST ALTERNATIVE**
Clinical monitoring (intermittent, reactive)

**KNOWN FAILURES**
  - Conditional on P-15/P-16 energy (if those fail, P-13 has no power source)

**REMAINING UNCERTAINTY**
Prediction accuracy on real patient data. Lead time in clinical setting.

**DECISIVE EXPERIMENT**
  Experiment: Retrospective: train on 100+ patient-years of shunt data. Test on held-out 20%.
  Pass: AUC >= 0.80 AND lead time >= 12h on held-out cohort
  Fail: AUC < 0.70
  Cost: $5-15K (ESTIMATED: compute + data access)
  Timeline: 2-4 weeks (ESTIMATED: data procurement + training)

**REGULATORY STATUS**
SaMD (Software as Medical Device) — FDA 510(k) or De Novo

**COMMERCIAL ROUTE**
License to hospital system or data company

**IP / DILIGENCE STATUS**
  BUYER_DILIGENCE_REQUIRED — no patent search performed
  Full freedom-to-operate analysis by buyer counsel
  (We are not running a patent court.)

**BUYER'S NEXT ACTION**
COMMISSION TEST — obtain shunt patient dataset, train predictor, test on held-out cohort
  BUYER_ACTION_ID: P13-EXP-001

**VALIDATION RESULTS** (computed by independent validator, not generator)
  Q1 (send without verbal): PASS
  Q2 (identify next step): PASS
  Q3 (facts vs hypotheses): PASS
  Q4 (challenge without trusting): PASS
  Errors: NONE

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━